| NCT Number | NCT06990893 |
| Lead Sponsor | Anqing Municipal Hospital |
| Conditions | Sufentanil, Morphine, Validity, Safety, Oliceridine |
| Enrollment | 90 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-10-01 (estimated) |
| Study Completion | 2026-10-01 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-01 |